FilingReader Intelligence
Fosun Pharma cuts private equity fund commitment by 7.6bn yuan
July 16, 2025 at 05:12 AM UTC•By FilingReader AI
Fosun Pharma's board approved a 7.6 billion yuan reduction in its Suzhou Angel Fund commitment, decreasing the total fund size to 10 billion yuan.
The adjustment, effective July 15, 2025, maintains Fosun Pharma's 62.50% stake in the fund.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Announcement of resolutions of the third meeting (interim meeting) of the tenth board of directors of Fosun PharmaJuly 15, 2025 at 08:00 AM UTC
Fosun Pharmaceutical bond proceeds management system (2025 revision)July 15, 2025 at 08:00 AM UTC
Fosun Pharma investor relations management measures (revised 2025)July 15, 2025 at 08:00 AM UTC
SSE:600196•Shanghai Stock Exchange
PharmaceuticalsShanghai Blue Chip
News Alerts
Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime